ARTICLE | Product Development

Multimodal meeting

ASH 2017 by the numbers: cell and gene therapies making inroads

December 9, 2017 4:21 AM UTC

This year’s clinical abstracts at the American Society of Hematology meeting hint at how newer treatment modalities -- cell therapies in cancer and gene therapies in hematology -- will branch out into new indications and fit into evolving treatment landscapes.

In advance of the conference, which runs Dec. 9-12 in Atlanta, BioCentury performed a series of manual and algorithm-guided analyses on 4,429 abstracts and identified 2,027 that concerned clinical studies of therapeutics, diagnostic or prognostic biomarkers...